#USA #Toronto #Wound Care #MolecuLight #DocNow

MolecuLight and DocNow: A Revolutionary Integration for Wound Management

On April 29, 2025, MolecuLight Inc., a global innovator in Point-of-Care fluorescence imaging for the prompt detection of infection-causing bacteria in wounds, announced its partnership with DocNow, an advanced electronic health record (EHR) platform focused on post-acute care. This collaboration aims to integrate MolecuLight's DX device with DocNow, enabling seamless data and image transfer that enhances the clinical workflow.

MolecuLight's technology revolutionizes the assessment of wounds, allowing healthcare professionals to detect bacterial presence rapidly and accurately. By integrating with DocNow, the process of documenting wounds becomes significantly streamlined, providing clinicians with immediate access to crucial information right at the patient's bedside.

Key Features of the Integration

The new integration allows for:
1. Direct and Automatic Upload: Clinicians can upload both standard and bacterial autofluorescence images efficiently via Wi-Fi, transferring crucial data directly into the patient's medical record on DocNow.
2. Comprehensive Wound Measurements: Automatic uploads will be facilitated for detailed wound assessments, including information on tunneling and undermining, crucial for effective treatment planning.
3. Offline Use Support: Mobile wound care providers will benefit from the 'offline use' capability, ensuring documentation remains complete even in settings without internet connectivity.
4. Embedded Integration with Workflows: The integration is seamlessly embedded within the DocNow 'patient census' workflow, making it user-friendly for clinicians.
5. Collaboration with Other Platforms: The MolecuLight integration fully incorporates with both PointClickCare and MatrixCare, allowing for precise documentation across post-acute care facilities.

Anil Amlani, CEO of MolecuLight Inc., emphasized the significance of this integration: "This partnership represents a substantial advancement in our commitment to delivering immediate, actionable insights to clinicians at the point of treatment. The MolecuLightDX, a Class II FDA-approved device, provides critical information about bacterial loads, enabling precise digital wound measurements. By integrating seamlessly with DocNow, we are broadening our reach into post-acute and mobile environments to enhance efficiency and patient outcomes across various healthcare settings."

Dr. Lauren Neuman, Chief Clinical Officer at DocNow, added, "Our mission at DocNow is to equip clinicians with intelligent, integrated tools to enhance patient care and streamline clinical workflows. Our collaboration with MolecuLight is a crucial step toward that vision. By integrating MolecuLight’s advanced fluorescence imaging technology directly into our EHR platform, we empower providers to visualize bacterial presence in real-time, allowing for more informed decisions in wound management and improving documentation accuracy. This collaboration not only supports better outcomes but also highlights our commitment to providing top-notch solutions for post-acute providers."

Overview of the Companies

MolecuLight Inc. is a private medical imaging company known for developing and distributing the MolecuLight iX® and DX™ wound imaging devices, the only FDA-approved Point-of-Care imaging devices in Class II that can detect increased bacterial burden in real time. These devices support a comprehensive approach to wound management with robust clinical evidence, backed by over 100 peer-reviewed publications.

DocNow operates as an EHR and virtual care platform tailored for post-acute care providers. It focuses on simplifying documentation, improving outcomes, and streamlining clinical and administrative workflows to support nursing teams across care facilities, long-term care, and home settings.

In summary, the partnership between MolecuLight and DocNow stands to significantly improve clinical outcomes in wound care, offering clinicians the tools they need for efficient, effective, and informed patient management.